Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists aspirin or direct acting oral anticoagulants

摘要

AimDirect‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs). The objective of the present study was to evaluate the risk of AMI in patients with AF who are exposed to either VKAs, DOACs or low‐dose (< 325 mg) aspirin.